<DOC>
	<DOCNO>NCT02443428</DOCNO>
	<brief_summary>The purpose prospective observational registry monitor safety eribulin routine clinical practice . Additionally , study also assess effectiveness eribulin real-life setting .</brief_summary>
	<brief_title>Eribulin Use Treatment Advanced Breast Cancer : A Prospective Observational Registry</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Inclusion Criteria The participant meet follow criterion eligible enter prospective registry : 1 . Participants older 18 year age 2 . Willing able provide inform consent 3 . Diagnosis locally advance metastatic breast cancer 4 . Progression two previous chemotherapy regimen advance disease . Prior therapy include anthracycline taxanes either adjuvant advance set unless suitable 5 . Adequate bone marrow , liver , renal function 6 . Life expectancy great 12 week Exclusion Criteria Participants meeting follow criterion permit enter study : 1 . Prior treatment eribulin 2 . Participants receive two prior chemotherapeutic regimen advance disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Breast Cancer</keyword>
</DOC>